CDK2-IN-19 (Compound 32) is a selective, orally active CDK2 inhibitor (K i: 0.18 nM) that demonstrates anticancer activity in mice with OVCAR3 tumors [1].
Molecular Weight:
460.48
Formula:
C20H21FN6O4S
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted
